• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于小肠细菌过度生长与肠易激综合征鉴别诊断的呼气试验:关于不可吸收抗生素的观察

Breath test for differential diagnosis between small intestinal bacterial overgrowth and irritable bowel disease: an observation on non-absorbable antibiotics.

作者信息

Esposito I, de Leone A, Di Gregorio G, Giaquinto S, de Magistris L, Ferrieri A, Riegler G

机构信息

Department of Clinical and Experimental Internal Medicine, Second University of Naples, Italy.

出版信息

World J Gastroenterol. 2007 Dec 7;13(45):6016-21. doi: 10.3748/wjg.v13.45.6016.

DOI:10.3748/wjg.v13.45.6016
PMID:18023092
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4250883/
Abstract

AIM

To estimate the prevalence of small intestine bacterial overgrowth (SIBO) among patients with an earlier diagnosis of irritable bowel disease (IBS) in our geographical area, and to collect information on the use of locally acting non-absorbable antibiotics in the management of SIBO.

METHODS

A non-interventional study was conducted in 73 consecutive patients with a symptom-based diagnosis.

RESULTS

When the patients underwent a "breath test", 33 (45.2%) showed the presence of a SIBO. After treatment with rifaximin 1,200 mg/d for seven days in 32 patients, 19 (59.4%) showed a negative "breath test" one week later as well as a significant reduction of symptoms, thus confirming the relationship between SIBO and many of the symptoms claimed by patients. In the other 13 patients, "breath test" remained positive, and a further cycle of treatment with ciprofloxacin 500 mg/d was given for 7 additional days, resulting in a negative "breath test" in one patient only.

CONCLUSION

(1) about half of the patients with a symptomatic diagnosis of IBS have actually SIBO, which is responsible for most of the symptoms attributed to IBS; (2) only a "breath test" with lactulose (or with glucose in subjects with an intolerance to lactose) can provide a differential diagnosis between IBS and SIBO, with almost identical symptoms; and (3) the use of non-absorbable antibiotics may be useful to reduce the degree of SIBO and related symptoms; it must be accompanied, however, by the correction of the wrong alimentary habits underlying SIBO.

摘要

目的

评估在我们所在地区较早诊断为肠易激综合征(IBS)的患者中,小肠细菌过度生长(SIBO)的患病率,并收集有关使用局部作用的不可吸收抗生素治疗SIBO的信息。

方法

对73例连续的基于症状诊断的患者进行了一项非干预性研究。

结果

当患者进行“呼气试验”时,33例(45.2%)显示存在SIBO。32例患者接受1200mg/d利福昔明治疗7天后,19例(59.4%)在一周后“呼气试验”呈阴性,且症状明显减轻,从而证实了SIBO与患者所声称的许多症状之间的关系。在另外13例患者中,“呼气试验”仍为阳性,另外给予500mg/d环丙沙星再治疗7天,结果仅1例患者“呼气试验”转为阴性。

结论

(1)约一半有症状诊断为IBS的患者实际上患有SIBO,这是IBS相关大多数症状的原因;(2)只有用乳果糖进行“呼气试验”(或对乳糖不耐受的患者用葡萄糖进行“呼气试验”)才能对症状几乎相同的IBS和SIBO进行鉴别诊断;(3)使用不可吸收抗生素可能有助于降低SIBO的程度和相关症状;然而,必须同时纠正SIBO潜在的不良饮食习惯。

相似文献

1
Breath test for differential diagnosis between small intestinal bacterial overgrowth and irritable bowel disease: an observation on non-absorbable antibiotics.用于小肠细菌过度生长与肠易激综合征鉴别诊断的呼气试验:关于不可吸收抗生素的观察
World J Gastroenterol. 2007 Dec 7;13(45):6016-21. doi: 10.3748/wjg.v13.45.6016.
2
A study of the methodological and clinical validity of the combined lactulose hydrogen breath test with scintigraphic oro-cecal transit test for diagnosing small intestinal bacterial overgrowth in IBS patients.一项关于联合使用乳果糖氢呼气试验与闪烁扫描法口盲肠转运试验诊断肠易激综合征(IBS)患者小肠细菌过度生长的方法学及临床有效性的研究。
Neurogastroenterol Motil. 2014 Jun;26(6):794-802. doi: 10.1111/nmo.12331. Epub 2014 Mar 18.
3
[Clinical features of irritable bowel syndrome with small intestinal bacterial overgrowth and a preliminary study of effectiveness of Rifaximin].小肠细菌过度生长型肠易激综合征的临床特征及利福昔明疗效的初步研究
Zhonghua Yi Xue Za Zhi. 2016 Jun 28;96(24):1896-902. doi: 10.3760/cma.j.issn.0376-2491.2016.24.005.
4
Small intestine bacterial overgrowth and irritable bowel syndrome-related symptoms: experience with Rifaximin.小肠细菌过度生长与肠易激综合征相关症状:利福昔明的应用经验
World J Gastroenterol. 2009 Jun 7;15(21):2628-31. doi: 10.3748/wjg.15.2628.
5
Comparison of lactulose and glucose breath test for diagnosis of small intestinal bacterial overgrowth in patients with irritable bowel syndrome.乳果糖和葡萄糖呼气试验诊断肠易激综合征患者小肠细菌过度生长的比较。
Digestion. 2012;85(3):243-7. doi: 10.1159/000336174. Epub 2012 Mar 30.
6
Clinical value of radionuclide small intestine transit time measurement combined with lactulose hydrogen breath test for the diagnosis of bacterial overgrowth in irritable bowel syndrome.放射性核素小肠转运时间测定联合乳果糖氢呼气试验对肠易激综合征中细菌过度生长诊断的临床价值
Hell J Nucl Med. 2016 May-Aug;19(2):124-9. doi: 10.1967/s002449910365. Epub 2016 Jun 22.
7
Breath tests in the diagnosis of small intestinal bacterial overgrowth in patients with irritable bowel syndrome in comparison with quantitative upper gut aspirate culture.与定量上消化道抽吸物培养相比,呼气试验在肠易激综合征患者小肠细菌过度生长诊断中的应用
Eur J Gastroenterol Hepatol. 2014 Jul;26(7):753-60. doi: 10.1097/MEG.0000000000000122.
8
[The dietary features of diarrhea predominant irritable bowel syndrome patients with small intestinal bowel overgrowth].腹泻型肠易激综合征合并小肠细菌过度生长患者的饮食特点
Zhonghua Nei Ke Za Zhi. 2017 Aug 1;56(8):567-571. doi: 10.3760/cma.j.issn.0578-1426.2017.08.003.
9
Short-course Rifaximin therapy efficacy and lactulose hydrogen breath test in Chinese patients with diarrhea-predominant irritable bowel syndrome.利福昔明短程疗法疗效及乳果糖氢呼气试验在腹泻型肠易激综合征中国患者中的应用。
BMC Gastroenterol. 2020 Jun 12;20(1):187. doi: 10.1186/s12876-020-01336-6.
10
Small Intestinal Bacterial Overgrowth and Irritable Bowel Syndrome: A Bridge between Functional Organic Dichotomy.小肠细菌过度生长与肠易激综合征:功能性与器质性二分法之间的桥梁
Gut Liver. 2017 Mar 15;11(2):196-208. doi: 10.5009/gnl16126.

引用本文的文献

1
Critical appraisal of the SIBO hypothesis and breath testing: A clinical practice update endorsed by the European society of neurogastroenterology and motility (ESNM) and the American neurogastroenterology and motility society (ANMS).小肠细菌过度生长(SIBO)假说和呼气试验的批判性评价:欧洲神经胃肠病学和动力学会(ESNM)和美国神经胃肠病学和动力学会(ANMS)认可的临床实践更新。
Neurogastroenterol Motil. 2024 Jun;36(6):e14817. doi: 10.1111/nmo.14817. Epub 2024 May 26.
2
A systematic review and meta-analysis on the prevalence of non-malignant, organic gastrointestinal disorders misdiagnosed as irritable bowel syndrome.一项关于被误诊为肠易激综合征的非恶性、器质性胃肠道疾病患病率的系统评价和荟萃分析。
Sci Rep. 2022 Feb 4;12(1):1949. doi: 10.1038/s41598-022-05933-1.
3
Risk Factors for Renal Impairment in Adult Patients With Short Bowel Syndrome.成年短肠综合征患者肾功能损害的危险因素
Front Nutr. 2021 Jan 18;7:618758. doi: 10.3389/fnut.2020.618758. eCollection 2020.
4
Anti-Helicobacter pylori treatment can effectively improve the clinical remission rates of irritable bowel syndrome: a controlled clinical trial meta-analysis.抗幽门螺杆菌治疗可有效提高肠易激综合征的临床缓解率:一项对照临床试验的荟萃分析。
Clinics (Sao Paulo). 2020 Nov 11;75:e1857. doi: 10.6061/clinics/2020/e1857. eCollection 2020.
5
Predictors of Small Intestinal Bacterial Overgrowth in Symptomatic Patients Referred for Breath Testing.因呼气试验转诊的有症状患者小肠细菌过度生长的预测因素
J Clin Med Res. 2020 Oct;12(10):655-661. doi: 10.14740/jocmr4320. Epub 2020 Sep 21.
6
Nutrient Challenge Testing Is Not Equivalent to Scintigraphy-Lactulose Hydrogen Breath Testing in Diagnosing Small Intestinal Bacterial Overgrowth.营养激发试验在诊断小肠细菌过度生长方面与闪烁扫描-乳果糖氢呼气试验并不等效。
J Neurogastroenterol Motil. 2020 Sep 30;26(4):514-520. doi: 10.5056/jnm19162.
7
Small Intestinal Bacterial Overgrowth Diagnosed by a Breath Test and Improved by Rifaximin in a Patient with Hepatic Encephalopathy and Alcoholic Liver Cirrhosis.小肠细菌过度生长通过呼气试验诊断,并通过利福昔明改善肝性脑病和酒精性肝硬化患者的病情。
Intern Med. 2020 Aug 1;59(15):1849-1853. doi: 10.2169/internalmedicine.4593-20. Epub 2020 Apr 23.
8
Congruency of Genetic Predisposition to Lactase Persistence and Lactose Breath Test.乳糖持续存在和乳糖呼气试验的遗传易感性一致性。
Nutrients. 2019 Jun 20;11(6):1383. doi: 10.3390/nu11061383.
9
Small Intestinal Bacterial Overgrowth in Patients With Cirrhosis.肝硬化患者的小肠细菌过度生长
J Clin Exp Hepatol. 2019 Mar-Apr;9(2):257-267. doi: 10.1016/j.jceh.2018.08.006. Epub 2018 Aug 27.
10
Therapeutic Effects of Low-dose Bismuth Subcitrate on Symptoms and Health-related Quality of Life in Adult Patients with Irritable Bowel Syndrome: A Clinical Trial.低剂量枸橼酸铋对成年肠易激综合征患者症状及健康相关生活质量的治疗作用:一项临床试验
J Res Pharm Pract. 2018 Jan-Mar;7(1):13-21. doi: 10.4103/jrpp.JRPP_17_56.

本文引用的文献

1
Efficacy of rifaximin, a nonabsorbed oral antibiotic, in the treatment of small intestinal bacterial overgrowth.利福昔明(一种不被吸收的口服抗生素)治疗小肠细菌过度生长的疗效。
Am J Med Sci. 2007 May;333(5):266-70. doi: 10.1097/MAJ.0b013e3180536784.
2
Small intestinal bacterial overgrowth in patients with irritable bowel syndrome.肠易激综合征患者的小肠细菌过度生长
Gut. 2007 Jun;56(6):802-8. doi: 10.1136/gut.2006.108712. Epub 2006 Dec 5.
3
Bacterial overgrowth as a cause of irritable bowel syndrome.细菌过度生长作为肠易激综合征的一个病因
Curr Opin Gastroenterol. 2006 Nov;22(6):669-73. doi: 10.1097/01.mog.0000245544.80160.46.
4
Utility of hydrogen breath tests in diagnosis of small intestinal bacterial overgrowth in malabsorption syndrome and its relationship with oro-cecal transit time.氢呼气试验在吸收不良综合征小肠细菌过度生长诊断中的应用及其与口盲肠转运时间的关系。
Indian J Gastroenterol. 2006 Jan-Feb;25(1):6-10.
5
Small intestine bacterial overgrowth in irritable bowel syndrome: a retrospective study with rifaximin.肠易激综合征中的小肠细菌过度生长:一项使用利福昔明的回顾性研究
Minerva Gastroenterol Dietol. 2006 Mar;52(1):89-95.
6
[Guidelines on intestinal dysmicrobism (SIBO Small Intestine Bacterial Overgrowth)].
Minerva Gastroenterol Dietol. 1999 Dec;45(4):297-308.
7
Management of small intestinal bacterial overgrowth.小肠细菌过度生长的管理。
Curr Gastroenterol Rep. 2005 Aug;7(4):317-20. doi: 10.1007/s11894-005-0025-x.
8
Detection of bacterial overgrowth in IBS using the lactulose H2 breath test: comparison with 14C-D-xylose and healthy controls.使用乳果糖氢呼气试验检测肠易激综合征中的细菌过度生长:与14C-D-木糖及健康对照的比较
Am J Gastroenterol. 2005 Jul;100(7):1566-70. doi: 10.1111/j.1572-0241.2005.40795.x.
9
Assessment of small intestinal bacterial overgrowth in uncomplicated acute diverticulitis of the colon.单纯性急性结肠憩室炎中小肠细菌过度生长的评估
World J Gastroenterol. 2005 May 14;11(18):2773-6. doi: 10.3748/wjg.v11.i18.2773.
10
Antibiotics for inflammatory bowel disease: do they work?
Eur J Gastroenterol Hepatol. 2005 Feb;17(2):145-7. doi: 10.1097/00042737-200502000-00003.